SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12B/A - Registration of securities [Section 12(b)]: [Amend]
SEC Accession No. 0001104659-13-049470
Filing Date
2013-06-14
Accepted
2013-06-14 17:29:58
Documents
10

Document Format Files

Seq Description Document Type Size
1 10-12B/A a13-11577_11012ba.htm 10-12B/A 2313490
2 EX-2.1 a13-11577_1ex2d1.htm EX-2.1 256146
3 EX-4.1 a13-11577_1ex4d1.htm EX-4.1 12262
4 EX-10.6 a13-11577_1ex10d6.htm EX-10.6 328711
5 EX-10.7 a13-11577_1ex10d7.htm EX-10.7 111241
6 EX-23.1 a13-11577_1ex23d1.htm EX-23.1 4980
7 GRAPHIC g115772kg1i001.gif GRAPHIC 316396
8 GRAPHIC g115771bc01i001.gif GRAPHIC 3728
9 GRAPHIC g115772kg3i001.gif GRAPHIC 106804
10 GRAPHIC g115771bc03i001.jpg GRAPHIC 37381
  Complete submission text file 0001104659-13-049470.txt   3668171
Mailing Address 4660 LA JOLLA VILLAGE DRIVE SUITE 500 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE SUITE 500 SAN DIEGO CA 92122 (514) 337-3333
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-12B/A | Act: 34 | File No.: 001-35921 | Film No.: 13915174
SIC: 2834 Pharmaceutical Preparations